Section Arrow
XCUR.NASDAQ
- Exicure Inc
(Financial Status)
Quotes are at least 15-min delayed:2024/12/23 22:17 EST
Last
 19.54
+0.87 (+4.66%)
Day High 
22.99 
Prev. Close
18.67 
1-M High
36 
Volume 
98.78K 
Bid
19.05
Ask
21.1
Day Low
18.37 
Open
18.7 
1-M Low
8.43 
Market Cap 
48.65M 
Currency USD 
P/E 0.16 
%Yield -- 
10-SMA 18.17 
20-SMA 21.05 
50-SMA 10.48 
52-W High 36 
52-W Low 1.44 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.02/-0.63
Enterprise Value
54.69M
Balance Sheet
Book Value Per Share
0.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
9.13
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.4031-0.2085-34.09%-- 
RAPTRAPT Therapeutics1.74+0.9146+110.81%-- 
TRAWTraws Pharma Inc12.57+7.55+150.40%-- 
CEROCERo Therapeutics Holdings0.0505-0.0056-9.98%-- 
RXRXRecursion Pharmaceuticals6.99+0.96+15.92%-- 
Quotes are at least 15-min delayed:2024/12/23 22:17 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.